What Happened?
Shares of wellness products company Nature’s Sunshine (NASDAQ: NATR) fell 4.3% in the afternoon session after the company's fourth-quarter earnings call revealed a decline in sales in a key market and rising costs.
Sales in the Asia Pacific region slipped 1% to $55.7 million compared to the strong prior-year quarter. At the same time, selling, general, and administrative expenses rose to $48.4 million from $43.7 million. This increase was driven by higher spending on digital ads and other costs. As a result, these expenses represented a larger portion of sales, climbing to 39.1% from 35.7% a year ago. Additionally, inventory levels increased, and the company expected them to rise further, which could pose a risk if customer demand were to change.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Nature's Sunshine? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Nature's Sunshine’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 4 months ago when the stock gained 26.3% on the news that the company reported strong third-quarter 2025 results that beat Wall Street's expectations and raised its full-year guidance. The wellness products company announced that its sales increased 12% year-over-year to $128.3 million, topping analyst estimates. Profitability also saw a significant boost, with adjusted earnings of $0.36 per share, more than double Wall Street's forecast of $0.16. The company's operational efficiency improved, with its operating margin expanding to 7% from 4.6% in the same quarter last year. In light of these positive results, Nature's Sunshine lifted its full-year 2025 forecast for both sales and adjusted EBITDA, signaling confidence in its continued business momentum.
Nature's Sunshine is up 17% since the beginning of the year, but at $24.55 per share, it is still trading 11.7% below its 52-week high of $27.80 from March 2026. Investors who bought $1,000 worth of Nature's Sunshine’s shares 5 years ago would now be looking at an investment worth $1,294.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
